Display options
Share it on

Case Rep Obstet Gynecol. 2016;2016:1712404. doi: 10.1155/2016/1712404. Epub 2016 Sep 07.

Apocrine Adenocarcinoma of the Vulva: A Case Report and Review of the Literature.

Case reports in obstetrics and gynecology

Kohei Aoyama, Hiroshi Matsushima, Morio Sawada, Taisuke Mori, Satoru Yasukawa, Jo Kitawaki

Affiliations

  1. Department of Obstetrics and Gynecology, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  2. Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  3. Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Obstetrics and Gynecology, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, Japan.
  4. Department of Surgical Pathology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

PMID: 27668109 PMCID: PMC5030426 DOI: 10.1155/2016/1712404

Abstract

Primary vulvar adenocarcinomas are very rare. We describe the rare case of primary vulvar apocrine adenocarcinoma, a histologically rare subtype of vulvar adenocarcinoma. A 57-year-old Japanese woman presented with an enlarging vulvar mass. A dark-red, hemorrhagic, ulcerated tumor was on the right side of the anterior labial commissure measuring approximately 3.5 × 3.5 cm. Preoperative biopsy showed poorly differentiated carcinoma with partial differentiation to adenocarcinoma. Systemic examination revealed lymph node metastases in both inguinal regions and no other primary source. We performed radical vulvectomy and bilateral inguinal and pelvic lymphadenectomy. Histopathologic diagnosis was apocrine adenocarcinoma of the vulva with inguinal lymph node metastases, pT1bN2bM0. Surgical margins were negative. The patient received no adjuvant chemotherapy or radiation. Inguinal lymph node recurrence occurred after six months. Reresection and adjuvant tomotherapy were performed. After a further 12 months of observation, no rerecurrence was observed. The patient is now on follow-up.

References

  1. J Clin Pathol. 2009 Mar;62(3):287-8 - PubMed
  2. Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):381-9 - PubMed
  3. Arch Pathol Lab Med. 1991 Dec;115(12):1249-54 - PubMed
  4. PLoS One. 2012;7(10):e47290 - PubMed
  5. Cochrane Database Syst Rev. 2000;(2):CD002036 - PubMed
  6. Obstet Gynecol. 1986 Dec;68(6):733-40 - PubMed
  7. Int J Dermatol. 2003 Jan;42(1):71-4 - PubMed
  8. Rev Paul Med. 1989 Mar-Apr;107(2):122-4 - PubMed
  9. Int J Gynecol Cancer. 2010 Jul;20(5):874-8 - PubMed
  10. Pathol Res Pract. 2009;205(2):131-5 - PubMed
  11. Acta Obstet Gynecol Scand. 1995 Aug;74(7):577-9 - PubMed
  12. Pathol Res Pract. 1981 May;171(3-4):353-61 - PubMed
  13. Dermatology. 1999;199(4):332-7 - PubMed
  14. Rare Tumors. 2013 Sep 09;5(3):e40 - PubMed
  15. Gynecol Oncol. 2003 Sep;90(3):601-4 - PubMed
  16. Am J Obstet Gynecol. 1960 Apr;79:692-7 - PubMed
  17. Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):24-7 - PubMed

Publication Types